Improvement of recalcitrant diabetic macular edema after peritoneal dialysis

Sally Ong, Akshay S. Thomas, Sharon Fekrat

Research output: Contribution to journalArticle

Abstract

Nephropathy may be an independent and contributory risk factor for diabetic macular edema (DME). A 69-year-old man who had previously been treated with panretinal laser photocoagulation for proliferative diabetic retinopathy as well as with steroid and anti-vascular endothelial growth factor injections for DME declined additional treatment for the DME, which was worse in the right eye. The DME was observed without further treatment for the next 36 months. Despite wellcontrolled blood sugar, blood pressure, and lipid levels, the DME remained unchanged. Peritoneal dialysis was started due to end-stage renal disease. Three months after commencing dialysis, the DME improved significantly.

Original languageEnglish (US)
Pages (from-to)834-837
Number of pages4
JournalOphthalmic Surgery Lasers and Imaging Retina
Volume48
Issue number10
DOIs
StatePublished - Oct 1 2017
Externally publishedYes

Fingerprint

Macular Edema
Peritoneal Dialysis
Light Coagulation
Diabetic Retinopathy
Vascular Endothelial Growth Factor A
Chronic Kidney Failure
Blood Glucose
Dialysis
Lasers
Steroids
Blood Pressure
Lipids
Injections
Therapeutics

ASJC Scopus subject areas

  • Surgery
  • Ophthalmology

Cite this

Improvement of recalcitrant diabetic macular edema after peritoneal dialysis. / Ong, Sally; Thomas, Akshay S.; Fekrat, Sharon.

In: Ophthalmic Surgery Lasers and Imaging Retina, Vol. 48, No. 10, 01.10.2017, p. 834-837.

Research output: Contribution to journalArticle

@article{f12eb2aef0b34aabafa849c1982f09aa,
title = "Improvement of recalcitrant diabetic macular edema after peritoneal dialysis",
abstract = "Nephropathy may be an independent and contributory risk factor for diabetic macular edema (DME). A 69-year-old man who had previously been treated with panretinal laser photocoagulation for proliferative diabetic retinopathy as well as with steroid and anti-vascular endothelial growth factor injections for DME declined additional treatment for the DME, which was worse in the right eye. The DME was observed without further treatment for the next 36 months. Despite wellcontrolled blood sugar, blood pressure, and lipid levels, the DME remained unchanged. Peritoneal dialysis was started due to end-stage renal disease. Three months after commencing dialysis, the DME improved significantly.",
author = "Sally Ong and Thomas, {Akshay S.} and Sharon Fekrat",
year = "2017",
month = "10",
day = "1",
doi = "10.3928/23258160-20170928-09",
language = "English (US)",
volume = "48",
pages = "834--837",
journal = "Ophthalmic Surgery Lasers and Imaging Retina",
issn = "2325-8160",
publisher = "Slack Incorporated",
number = "10",

}

TY - JOUR

T1 - Improvement of recalcitrant diabetic macular edema after peritoneal dialysis

AU - Ong, Sally

AU - Thomas, Akshay S.

AU - Fekrat, Sharon

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Nephropathy may be an independent and contributory risk factor for diabetic macular edema (DME). A 69-year-old man who had previously been treated with panretinal laser photocoagulation for proliferative diabetic retinopathy as well as with steroid and anti-vascular endothelial growth factor injections for DME declined additional treatment for the DME, which was worse in the right eye. The DME was observed without further treatment for the next 36 months. Despite wellcontrolled blood sugar, blood pressure, and lipid levels, the DME remained unchanged. Peritoneal dialysis was started due to end-stage renal disease. Three months after commencing dialysis, the DME improved significantly.

AB - Nephropathy may be an independent and contributory risk factor for diabetic macular edema (DME). A 69-year-old man who had previously been treated with panretinal laser photocoagulation for proliferative diabetic retinopathy as well as with steroid and anti-vascular endothelial growth factor injections for DME declined additional treatment for the DME, which was worse in the right eye. The DME was observed without further treatment for the next 36 months. Despite wellcontrolled blood sugar, blood pressure, and lipid levels, the DME remained unchanged. Peritoneal dialysis was started due to end-stage renal disease. Three months after commencing dialysis, the DME improved significantly.

UR - http://www.scopus.com/inward/record.url?scp=85031664860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031664860&partnerID=8YFLogxK

U2 - 10.3928/23258160-20170928-09

DO - 10.3928/23258160-20170928-09

M3 - Article

C2 - 29020428

AN - SCOPUS:85031664860

VL - 48

SP - 834

EP - 837

JO - Ophthalmic Surgery Lasers and Imaging Retina

JF - Ophthalmic Surgery Lasers and Imaging Retina

SN - 2325-8160

IS - 10

ER -